Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Stintzing

Showing results (41-50 of 206) with videos related to

Pageof 21
Sort By:
Frontiers in Oncology|November 22, 2021
Survey of Long-Term Experiences of Sperm Cryopreservation in Oncological and Non-Oncological Patients: Usage and Reproductive Outcomes of a Large Monocentric CohortNadine Lackamp, Ina Wilkemeyer, Ivan Jelas, et al.
Oncology Research and Treatment|June 4, 2025
A Current Assessment of the Use of Complementary Medicine in German Cancer Patients: The CONKO 022 InvestigationTobias Bleumer, Janine Abel, Lilian Bodden, et al.
Cureus|April 22, 2020
Frameless Single Robotic Radiosurgery for Pulmonary Metastases in Colorectal Cancer PatientsJobst C Von Einem, Sebastian Stintzing, Dominik P Modest, et al.
Critical Reviews in Oncology/Hematology|March 28, 2022
Systematic review of randomised clinical trials and observational studies for patients with RAS wild-type or BRAF<sup>V600E</sup>-mutant metastatic and/or unresectable colorectal cancerPilar García-Alfonso, Astrid Lièvre, Fotios Loupakis, et al.
Frontiers in Oncology|October 17, 2019
Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid TumorsJesús García-Foncillas, Yu Sunakawa, Dan Aderka, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2016
A study-level meta-analysis of efficacy data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in patients with RAS wild-type metastatic colorectal cancerVolker Heinemann, Fernando Rivera, Bert H O'Neil, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 28, 2005
Different capabilities of morphological pattern formation and its association with the expression of differentiation markers in a xenograft model of human pancreatic cancer cell linesDaniel Neureiter, Steffen Zopf, Arno Dimmler, et al.
BMC Cancer|March 15, 2024
Role of beta-(1→3)(1→6)-D-glucan derived from yeast on natural killer (NK) cells and breast cancer cell lines in 2D and 3D culturesAbdelhadi Boulifa, Martin J Raftery, Alexander Sebastian Franzén, et al.
Frontiers in Oncology|August 8, 2022
PD-L1 Amino Acid Position 88 Represents a Hotspot for PD-L1 Stability With Relevance for PD-L1 InhibitionLuise Victoria Claaß, Christoph Schultheiß, Rebekka Scholz, et al.
Clinical Colorectal Cancer|June 9, 2018
Association Between Height and Clinical Outcome in Metastatic Colorectal Cancer Patients Enrolled Onto a Randomized Phase 3 Clinical Trial: Data From the FIRE-3 StudyMichelle McSkane, Sebastian Stintzing, Volker Heinemann, et al.
Pageof 21

Showing results (41-50 of 206) with videos related to

Sort By:
Pageof 21
Frontiers in Oncology|November 22, 2021
Survey of Long-Term Experiences of Sperm Cryopreservation in Oncological and Non-Oncological Patients: Usage and Reproductive Outcomes of a Large Monocentric CohortNadine Lackamp, Ina Wilkemeyer, Ivan Jelas, et al.
Oncology Research and Treatment|June 4, 2025
A Current Assessment of the Use of Complementary Medicine in German Cancer Patients: The CONKO 022 InvestigationTobias Bleumer, Janine Abel, Lilian Bodden, et al.
Cureus|April 22, 2020
Frameless Single Robotic Radiosurgery for Pulmonary Metastases in Colorectal Cancer PatientsJobst C Von Einem, Sebastian Stintzing, Dominik P Modest, et al.
Critical Reviews in Oncology/Hematology|March 28, 2022
Systematic review of randomised clinical trials and observational studies for patients with RAS wild-type or BRAF<sup>V600E</sup>-mutant metastatic and/or unresectable colorectal cancerPilar García-Alfonso, Astrid Lièvre, Fotios Loupakis, et al.
Frontiers in Oncology|October 17, 2019
Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid TumorsJesús García-Foncillas, Yu Sunakawa, Dan Aderka, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2016
A study-level meta-analysis of efficacy data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in patients with RAS wild-type metastatic colorectal cancerVolker Heinemann, Fernando Rivera, Bert H O'Neil, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 28, 2005
Different capabilities of morphological pattern formation and its association with the expression of differentiation markers in a xenograft model of human pancreatic cancer cell linesDaniel Neureiter, Steffen Zopf, Arno Dimmler, et al.
BMC Cancer|March 15, 2024
Role of beta-(1→3)(1→6)-D-glucan derived from yeast on natural killer (NK) cells and breast cancer cell lines in 2D and 3D culturesAbdelhadi Boulifa, Martin J Raftery, Alexander Sebastian Franzén, et al.
Frontiers in Oncology|August 8, 2022
PD-L1 Amino Acid Position 88 Represents a Hotspot for PD-L1 Stability With Relevance for PD-L1 InhibitionLuise Victoria Claaß, Christoph Schultheiß, Rebekka Scholz, et al.
Clinical Colorectal Cancer|June 9, 2018
Association Between Height and Clinical Outcome in Metastatic Colorectal Cancer Patients Enrolled Onto a Randomized Phase 3 Clinical Trial: Data From the FIRE-3 StudyMichelle McSkane, Sebastian Stintzing, Volker Heinemann, et al.
Pageof 21